10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 250 filers reported holding 10X GENOMICS INC in Q2 2022. The put-call ratio across all filers is 0.59 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,694,285 | -30.0% | 65,316 | -5.2% | 0.50% | -25.9% |
| Q2 2023 | $3,848,493 | -4.2% | 68,920 | -4.3% | 0.67% | -11.1% |
| Q1 2023 | $4,016,825 | +105.5% | 71,999 | +34.2% | 0.75% | +72.6% |
| Q4 2022 | $1,954,897 | +16.5% | 53,647 | -9.0% | 0.44% | +19.8% |
| Q3 2022 | $1,678,000 | -38.7% | 58,932 | -2.6% | 0.36% | -45.4% |
| Q2 2022 | $2,737,000 | -13.9% | 60,492 | +44.8% | 0.66% | +12.0% |
| Q1 2022 | $3,179,000 | +24.1% | 41,790 | +143.0% | 0.59% | +35.6% |
| Q4 2021 | $2,561,000 | +91.7% | 17,195 | +87.4% | 0.44% | +78.8% |
| Q3 2021 | $1,336,000 | -20.8% | 9,176 | +6.5% | 0.24% | -23.2% |
| Q2 2021 | $1,687,000 | +54.1% | 8,614 | +42.3% | 0.32% | +34.0% |
| Q1 2021 | $1,095,000 | +74.9% | 6,052 | +37.0% | 0.24% | +58.7% |
| Q4 2020 | $626,000 | +8842.9% | 4,416 | +7513.8% | 0.15% | +7400.0% |
| Q3 2020 | $7,000 | – | 58 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |